Bimoptik Romfarm cap. eye. solution 0.3mg/ml fl. 3 ml No. 1

Drops eye Bimoptik Romfarm is shown for decrease in the increased intraocular pressure (VGD) at adult patients with a chronic open angle glaucoma and intraocular hypertensia (as monotherapy or additional therapy to beta blockers).

Structure

Active ingredient: bimatoprost;

1 ml of solution - 0.3 mg of the bimatoprost;

Excipients: benzalkoniya chloride, sodium phosphate, heptahydrate; citric acid monohydrate, sodium chloride, sodium hydroxide of 1 M or hydrochloric acid 1M; the water purified.

Contraindication

Hypersensitivity to active ingredient or the excipients which are a part of medicine including to a chloride benzalkoniya.

Route of administration

is Applied the adult: on 1 drop dig in in the affected eye (eyes) of 1 times a day in the evening.

Dose should not exceed 1 introductions of 1 times a day as more frequent use of medicine can reduce effect of decrease in the increased intraocular pressure.

Feature of application

Pregnant

Bimatoprost should not be applied during pregnancy, except emergency cases.

Children

It is contraindicated.

Bimatoprost insignificant influence on speed of response at control of motor transport or work with other mechanisms has

. As well as in case of application of other eye drops if after burying there is a temporary illegibility of sight, the patient needs to wait so far the sight will be restored before steering motor transport or to work with mechanisms.

Overdose

About cases of overdose of medicine of Bimikan Eco was not reported. At topical administration in the form of eye drops of overdose it is improbable.

in case of overdose needs the supporting and symptomatic therapy.

Side effects

• from nervous system: headache, dizziness.
• from an organ of sight: conjunctiva hyperaemia, (superficial) speckled keratitis, irritation of eyes, feeling of a foreign body in an eye, dryness in eyes, eye pain, an itch, increase in growth of eyelashes, reddening the century, an asthenopia, a chemosis, photophobia, dacryagogue, a hyperpegmentation of an iris of the eye, disorder of vision / illegibility of sight, an itch a century, swelled a century, a cornea erosion, burning sensation in eyes, allergic conjunctivitis, blepharitis, deterioration in visual acuity, eye discharges, darkening of eyelashes, retinal apoplexies, a nictitating spasm, retraction a century, conjunctival frustration, madaroz (loss of eyelashes or eyebrows), pigmentation a century, swelled an eye, a uveitis, an iritis.
• from a cardiovascular system: arterial hypertension.
• from a digestive tract: nausea.
• from skin and its derivatives: skin hyperpegmentation (periorbital site), hypertrichosis (pathological growth of hair), reddening periorbital site, xeroderma, crusting on the edge century, itch.
• from the respiratory system and bodies of mediastinum: asthma, exacerbation of bronchial asthma, aggravation HOBL and short wind.
• from the immune system: reactions of hypersensitivity, including signs and symptoms of an eye allergy and allergic dermatitis.
• General violations and changes in the injection site: an adynamy, irritation in the place of instillation.

Interaction

Research of interaction was not conducted.

to Store

in original packing out of children's reach.

does not demand special storage conditions.

Expiration date - 3 years.